Monoclonal antibody against citrullinated peptides obtained from rheumatoid arthritis patients reacts with numerous citrullinated microbial and food proteins

Arthritis and Rheumatology

Volumn 67, Issue 8, 2015, Pages 2020-2031

  Tsuda, Reina ^a   Ozawa, Tatsuhiko ^a   Kobayashi, Eiji ^a   Hamana, Hiroshi ^a   Taki, Hirofumi ^a   Tobe, Kazuyuki ^a   Sugiyama, Eiji ^a   Iwamoto, Masahiro ^b,c   Imura, Johji ^a,d   Kishi, Hiroyuki ^a,e   Muraguchi, Atsushi ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b University Hospital   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AUTOANTIGEN; BACTERIAL PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY 1; EPITOPE; FUNGAL PROTEIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VEGETABLE PROTEIN; VIRUS PROTEIN; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE;

ADULT; AGED; ANTIBODY SECRETING CELL; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSPOT ASSAY; EPITOPE MAPPING; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTAKE; RHEUMATOID ARTHRITIS; VERY ELDERLY; CROSS REACTION; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; B-LYMPHOCYTES; BACTERIAL PROTEINS; CROSS REACTIONS; EPITOPE MAPPING; EPITOPES; FEMALE; FUNGAL PROTEINS; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PLANT PROTEINS; VEGETABLE PROTEINS; VIRAL PROTEINS;

EID: 84938149885     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39161     Document Type: Article

References (54)

1. Carmona L, Cross M, Williams B, Lassere M, March L., Rheumatoid arthritis. Best Pract Res Clin Rheumatol 2010; 24: 733-45.
2. Berglin E, Padyukov L, Sundin U, Hallmans G, Stenlund H, Van Venrooij WJ, et al., A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther 2004; 6: R303-8.
3. Van Gaalen FA, van Aken J, Huizinga TW, Schreuder GM, Breedveld FC, Zanelli E, et al., Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum 2004; 50: 2113-21.
4. Auger I, Sebbag M, Vincent C, Balandraud N, Guis S, Nogueira L, et al., Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen. Arthritis Rheum 2005; 52: 3424-32.
5. Van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, de Vries RR., The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 2006; 54: 1117-21.
6. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, et al., Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004; 50: 380-6.
7. Van Venrooij WJ, van Beers JJ, Pruijn GJ., Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis. Ann N Y Acad Sci 2008; 1143: 268-85.
8. Van Venrooij WJ, van Beers JJ, Pruijn GJ., Anti-CCP antibodies: the past, the present and the future. Nat Rev Rheumatol 2011; 7: 391-8.
9. Wegner N, Lundberg K, Kinloch A, Fisher B, Malmstrom V, Feldmann M, et al., Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev 2010; 233: 34-54.
10. Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, et al., The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the α- and β-chains of fibrin. J Immunol 2001; 166: 4177-84.
11. Vossenaar ER, Despres N, Lapointe E, van der Heijden A, Lora M, Senshu T, et al., Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 2004; 6: R142-50.
12. Pratesi F, Tommasi C, Anzilotti C, Chimenti D, Migliorini P., Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheum 2006; 54: 733-41.
13. Sebbag M, Moinard N, Auger I, Clavel C, Arnaud J, Nogueira L, et al., Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins. Eur J Immunol 2006; 36: 2250-63.
14. Snir O, Widhe M, Hermansson M, von Spee C, Lindberg J, Hensen S, et al., Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients. Arthritis Rheum 2010; 62: 44-52.
15. Ioan-Facsinay A, el-Bannoudi H, Scherer HU, van der Woude D, Menard HA, Lora M, et al., Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities. Ann Rheum Dis 2011; 70: 188-93.
16. Willemze A, Bohringer S, Knevel R, Levarht EW, Stoeken-Rijsbergen G, Houwing-Duistermaat JJ, et al., The ACPA recognition profile and subgrouping of ACPA-positive RA patients. Ann Rheum Dis 2012; 71: 268-74.
17. Simon M, Girbal E, Sebbag M, Gomes-Daudrix V, Vincent C, Salama G, et al., The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis. J Clin Invest 1993; 92: 1387-93.
18. Sebbag M, Simon M, Vincent C, Masson-Bessiere C, Girbal E, Durieux JJ, et al., The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 1995; 95: 2672-9.
19. Girbal-Neuhauser E, Durieux JJ, Arnaud M, Dalbon P, Sebbag M, Vincent C, et al., The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 1999; 162: 585-94.
20. Amara K, Steen J, Murray F, Morbach H, Fernandez-Rodriguez BM, Joshua V, et al., Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition. J Exp Med 2013; 210: 445-55.
21. Jin A, Ozawa T, Tajiri K, Obata T, Kishi H, Muraguchi A., Rapid isolation of antigen-specific antibody-secreting cells using a chip-based immunospot array. Nat Protoc 2011; 6: 668-76.
22. Jin A, Ozawa T, Tajiri K, Obata T, Kondo S, Kinoshita K, et al., A rapid and efficient single-cell manipulation method for screening antigen-specific antibody-secreting cells from human peripheral blood. Nat Med 2009; 15: 1088-92.
23. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
24. Ozawa T, Jin A, Tajiri K, Takemoto M, Okuda T, Shiraki K, et al., Characterization of a fully human monoclonal antibody against extracellular domain of matrix protein 2 of influenza A virus. Antiviral Res 2011; 91: 283-7.
25. Kobayashi E, Mizukoshi E, Kishi H, Ozawa T, Hamana H, Nagai T, et al., A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days. Nat Med 2013; 19: 1542-6.
26. Ozawa T, Kinoshita K, Kadowaki S, Tajiri K, Kondo S, Honda R, et al., MAC-CCD system: a novel lymphocyte microwell-array chip system equipped with CCD scanner to generate human monoclonal antibodies against influenza virus. Lab Chip 2009; 9: 158-63.
27. Tajiri K, Kishi H, Tokimitsu Y, Kondo S, Ozawa T, Kinoshita K, et al., Cell-microarray analysis of antigen-specific B-cells: single cell analysis of antigen receptor expression and specificity. Cytometry A 2007; 71: 961-7.
28. Tokimitsu Y, Kishi H, Kondo S, Honda R, Tajiri K, Motoki K, et al., Single lymphocyte analysis with a microwell array chip. Cytometry A 2007; 71: 1003-10.
29. Ozawa T, Kishi H, Muraguchi A., Amplification and analysis of cDNA generated from a single cell by 5′-RACE: application to isolation of antibody heavy and light chain variable gene sequences from single B cells. Biotechniques 2006; 40: 469-78.
30. Giudicelli V, Chaume D, Lefranc MP., IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis. Nucleic Acids Res 2004; 32: W435-40.
31. Takai K, Sawasaki T, Endo Y., Practical cell-free protein synthesis system using purified wheat embryos. Nat Protoc 2010; 5: 227-38.
32. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ., Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101: 273-81.
33. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, et al., The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155-63.
34. Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R., Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis [published erratum appears in Clin Chem 2001; 47: 1748 ]. Clin Chem 2001;47:1089-93.
35. Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, et al., Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000; 2: 236-43.
36. Morrison KL, Weiss GA., Combinatorial alanine-scanning. Curr Opin Chem Biol 2001; 5: 302-7.
37. Cunningham BC, Wells JA., High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science 1989; 244: 1081-5.
38. Harre U, Kittan NA, Schett G., Autoantibody-mediated bone loss. Curr Osteoporos Rep 2014; 12: 17-21.
39. Van der Woude D, Rantapaa-Dahlqvist S, Ioan-Facsinay A, Onnekink C, Schwarte CM, Verpoort KN, et al., Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Ann Rheum Dis 2010; 69: 1554-61.
40. Lundberg K, Kinloch A, Fisher BA, Wegner N, Wait R, Charles P, et al., Antibodies to citrullinated α-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum 2008; 58: 3009-19.
41. Verpoort KN, Cheung K, Ioan-Facsinay A, van der Helm-van Mil AH, de Vries-Bouwstra JK, Allaart CF, et al., Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles. Arthritis Rheum 2007; 56: 3949-52.
42. Kinloch A, Tatzer V, Wait R, Peston D, Lundberg K, Donatien P, et al., Identification of citrullinated α-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther 2005; 7: R1421-9.
43. Lundberg K, Wegner N, Yucel-Lindberg T, Venables PJ., Periodontitis in RA: the citrullinated enolase connection. Nat Rev Rheumatol 2010; 6: 727-30.
44. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, et al., Novel regulators of bone formation: molecular clones and activities. Science 1988; 242: 1528-34.
45. Benckert J, Schmolka N, Kreschel C, Zoller MJ, Sturm A, Wiedenmann B, et al., The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific. J Clin Invest 2011; 121: 1946-55.
46. Czerkinsky C, Prince SJ, Michalek SM, Jackson S, Russell MW, Moldoveanu Z, et al., IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans. Proc Natl Acad Sci U S A 1987; 84: 2449-53.
47. Kokkonen H, Mullazehi M, Berglin E, Hallmans G, Wadell G, Ronnelid J, et al., Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis. Arthritis Res Ther 2011; 13: R13.
48. McGraw WT, Potempa J, Farley D, Travis J., Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun 1999; 67: 3248-56.
49. Wegner N, Wait R, Sroka A, Eick S, Nguyen KA, Lundberg K, et al., Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum 2010; 62: 2662-72.
50. Saal JG, Krimmel M, Steidle M, Gerneth F, Wagner S, Fritz P, et al., Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope. Arthritis Rheum 1999; 42: 1485-96.
51. Moen K, Brun JG, Valen M, Skartveit L, Eribe EK, Olsen I, et al., Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clin Exp Rheumatol 2006; 24: 656-63.
52. Karlson EW, van Schaardenburg D, van der Helm-van Mil AH., Strategies to predict rheumatoid arthritis development in at-risk populations. Rheumatology (Oxford) 2014. E-pub ahead of print.
53. Padyukov L, Seielstad M, Ong RT, Ding B, Ronnelid J, Seddighzadeh M, et al., A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis. Ann Rheum Dis 2011; 70: 259-65.
54. Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E., The conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1 0401 MHC class II molecule. J Immunol 2003; 171: 538-41.